Rivastigmine Tartrate Patent Expiration
Rivastigmine Tartrate is Used for managing symptoms of Alzheimer's dementia. It was first introduced by Novartis Pharmaceuticals Corp
Rivastigmine Tartrate Patents
Given below is the list of patents protecting Rivastigmine Tartrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Exelon | US5602176 | Phenyl carbamate |
Feb 11, 2014
(Expired) | Novartis |
| Exelon | US4948807 | Phenyl carbamates |
Aug 14, 2012
(Expired) | Novartis |
Rivastigmine Tartrate's Family Patents
Explore Our Curated Drug Screens
Rivastigmine Tartrate Generic API Manufacturers
Several generic applications have been filed for Rivastigmine Tartrate. The first generic version for Rivastigmine Tartrate was by Sun Pharmaceutical Industries Ltd and was approved on Oct 22, 2007. And the latest generic version is by Chartwell Rx Sciences Llc and was approved on Sep 28, 2017.
Given below is the list of companies who have filed for Rivastigmine Tartrate generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC PHARMS LTD
Alembic Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Rivastigmine Tartrate. Given below are the details of the strengths of this generic introduced by Alembic Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 6MG BASE | capsule | Prescription | ORAL | AB | Jun 12, 2012 |
| EQ 4.5MG BASE | capsule | Prescription | ORAL | AB | Jun 12, 2012 |
| EQ 3MG BASE | capsule | Prescription | ORAL | AB | Jun 12, 2012 |
| EQ 1.5MG BASE | capsule | Prescription | ORAL | AB | Jun 12, 2012 |
2. APOTEX INC
Apotex Inc has filed for 4 different strengths of generic version for Rivastigmine Tartrate. Given below are the details of the strengths of this generic introduced by Apotex Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 3MG BASE | capsule | Discontinued | ORAL | N/A | May 16, 2013 |
| EQ 1.5MG BASE | capsule | Discontinued | ORAL | N/A | May 16, 2013 |
| EQ 4.5MG BASE | capsule | Discontinued | ORAL | N/A | May 16, 2013 |
| EQ 6MG BASE | capsule | Discontinued | ORAL | N/A | May 16, 2013 |
Manufacturing Plant Locations New
Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| Canada |
| |||||||
3. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Rivastigmine Tartrate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1.5MG BASE | capsule | Prescription | ORAL | AB | Mar 25, 2016 |
| EQ 6MG BASE | capsule | Prescription | ORAL | AB | Mar 25, 2016 |
| EQ 4.5MG BASE | capsule | Prescription | ORAL | AB | Mar 25, 2016 |
| EQ 3MG BASE | capsule | Prescription | ORAL | AB | Mar 25, 2016 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
4. CADILA PHARMS LTD
Cadila Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Rivastigmine Tartrate. Given below are the details of the strengths of this generic introduced by Cadila Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4.5MG BASE | capsule | Prescription | ORAL | AB | Feb 13, 2017 |
| EQ 1.5MG BASE | capsule | Prescription | ORAL | AB | Feb 13, 2017 |
| EQ 3MG BASE | capsule | Prescription | ORAL | AB | Feb 13, 2017 |
| EQ 6MG BASE | capsule | Prescription | ORAL | AB | Feb 13, 2017 |
5. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 4 different strengths of generic version for Rivastigmine Tartrate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1.5MG BASE | capsule | Prescription | ORAL | AB | Sep 28, 2017 |
| EQ 3MG BASE | capsule | Prescription | ORAL | AB | Sep 28, 2017 |
| EQ 4.5MG BASE | capsule | Prescription | ORAL | AB | Sep 28, 2017 |
| EQ 6MG BASE | capsule | Prescription | ORAL | AB | Sep 28, 2017 |
6. DR REDDYS LABS INC
Dr Reddys Laboratories Inc has filed for 4 different strengths of generic version for Rivastigmine Tartrate. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 3MG BASE | capsule | Prescription | ORAL | AB | Oct 31, 2007 |
| EQ 1.5MG BASE
(reference standard) | capsule | Prescription | ORAL | AB | Oct 31, 2007 |
| EQ 4.5MG BASE | capsule | Prescription | ORAL | AB | Oct 31, 2007 |
| EQ 6MG BASE
(reference standard) | capsule | Prescription | ORAL | AB | Oct 31, 2007 |
7. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Rivastigmine Tartrate. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1.5MG BASE | capsule | Prescription | ORAL | AB | Aug 22, 2014 |
| EQ 6MG BASE | capsule | Prescription | ORAL | AB | Aug 22, 2014 |
| EQ 4.5MG BASE | capsule | Prescription | ORAL | AB | Aug 22, 2014 |
| EQ 3MG BASE | capsule | Prescription | ORAL | AB | Aug 22, 2014 |
8. ORBION PHARMS
Orbion Pharmaceuticals Private Ltd has filed for 4 different strengths of generic version for Rivastigmine Tartrate. Given below are the details of the strengths of this generic introduced by Orbion Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1.5MG BASE | capsule | Prescription | ORAL | AB | Jun 10, 2015 |
| EQ 4.5MG BASE | capsule | Prescription | ORAL | AB | Jun 10, 2015 |
| EQ 3MG BASE | capsule | Prescription | ORAL | AB | Jun 10, 2015 |
| EQ 6MG BASE | capsule | Prescription | ORAL | AB | Jun 10, 2015 |
9. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Rivastigmine Tartrate. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 6MG BASE | capsule | Discontinued | ORAL | N/A | Oct 22, 2007 |
| EQ 4.5MG BASE | capsule | Discontinued | ORAL | N/A | Oct 22, 2007 |
| EQ 3MG BASE | capsule | Discontinued | ORAL | N/A | Oct 22, 2007 |
| EQ 1.5MG BASE | capsule | Discontinued | ORAL | N/A | Oct 22, 2007 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||
10. WATSON LABS
Watson Laboratories Inc has filed for 4 different strengths of generic version for Rivastigmine Tartrate. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 6MG BASE | capsule | Prescription | ORAL | AB | Jan 8, 2008 |
| EQ 4.5MG BASE | capsule | Prescription | ORAL | AB | Jan 8, 2008 |
| EQ 3MG BASE | capsule | Prescription | ORAL | AB | Jan 8, 2008 |
| EQ 1.5MG BASE | capsule | Prescription | ORAL | AB | Jan 8, 2008 |